These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23537736)

  • 1. A fresh look at analytical performance specifications from biological variation.
    Stepman HC; Stöckl D; Twomey PJ; Thienpont LM
    Clin Chim Acta; 2013 Jun; 421():191-2. PubMed ID: 23537736
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality control and analytical techniques for biopharmaceuticals.
    Robinson CJ; Jones C
    Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sound science versus anxiety: validation of bioanalytical assays for small molecules.
    Svensson LD
    Bioanalysis; 2011 Dec; 3(24):2685-9. PubMed ID: 22185264
    [No Abstract]   [Full Text] [Related]  

  • 4. Incurred sample reanalysis.
    Booth B
    Bioanalysis; 2011 May; 3(9):927-8. PubMed ID: 21545337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical goals for interference.
    Fuentes-Arderiu X; Fraser CG
    Ann Clin Biochem; 1991 Jul; 28 ( Pt 4)():393-5. PubMed ID: 1892351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical performance specifications for changes in assay bias (Δbias) for data with logarithmic distributions as assessed by effects on reference change values.
    Petersen PH; Lund F; Fraser CG; Sölétormos G
    Ann Clin Biochem; 2016 Nov; 53(6):686-691. PubMed ID: 27147623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the confidence interval of the mean to detect systematic errors in one analytical run.
    Asberg A; Bolann B; Mikkelsen G
    Scand J Clin Lab Invest; 2010 Oct; 70(6):410-4. PubMed ID: 20602577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [GBEA and pipettes].
    Dhondt C; Hayte JM; Dhondt JL
    Ann Biol Clin (Paris); 1997; 55(3):252-3. PubMed ID: 9238431
    [No Abstract]   [Full Text] [Related]  

  • 9. New section on standard method performance requirements.
    Rathbone R
    J AOAC Int; 2011; 94(4):45A. PubMed ID: 21919332
    [No Abstract]   [Full Text] [Related]  

  • 10. Rationale for using data on biological variation.
    Ricós C; Álvarez V; Perich C; Fernández-Calle P; Minchinela J; Cava F; Biosca C; Boned B; Doménech M; García-Lario JV; Simón M; Fernández PF; Diaz-Garzón J; González-Lao E
    Clin Chem Lab Med; 2015 May; 53(6):863-70. PubMed ID: 25928757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moving Average for Continuous Quality Control: Time to Move to Implementation in Daily Practice?
    van Rossum HH; Kemperman H
    Clin Chem; 2017 May; 63(5):1041-1043. PubMed ID: 28320760
    [No Abstract]   [Full Text] [Related]  

  • 12. Conference Report: Analytical challenges in the qualification and validation of pharmacodynamic biomarkers.
    Houghton R; Chamberlain J
    Bioanalysis; 2011 May; 3(9):945-8. PubMed ID: 21545341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incurred sample reanalysis: dilemma in its applicability - should it be practiced for all bioanalytical assays involving single (parent or metabolite) or multiple analytes (parent/metabolite or parent with co-administered drugs)?
    Srinivas NR
    Biomed Chromatogr; 2011 Jun; 25(6):737-9. PubMed ID: 21465501
    [No Abstract]   [Full Text] [Related]  

  • 14. Handling false negatives, false positives and reporting limits in analytical proficiency tests.
    Analytical Methods Committee
    Analyst; 1997 May; 122(5):495-7. PubMed ID: 9246820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The certainty of uncertainty.
    Horwitz W
    J AOAC Int; 2003; 86(1):109-11. PubMed ID: 12607748
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of assay validation in specification development.
    Baffi RA
    Dev Biol Stand; 1997; 91():105-13. PubMed ID: 9413687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What information on quality specifications should be communicated to clinicians, and how?
    Plebani M
    Clin Chim Acta; 2004 Aug; 346(1):25-35. PubMed ID: 15234633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus assay methods: accuracy and validation.
    Darling AJ; Boose JA; Spaltro J
    Biologicals; 1998 Jun; 26(2):105-10. PubMed ID: 9811514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incurred sample reanalysis: it is just a matter of good scientific practice.
    Kelley M
    Bioanalysis; 2011 May; 3(9):931-2. PubMed ID: 21545338
    [No Abstract]   [Full Text] [Related]  

  • 20. Validation of bioassays for quality control.
    Lansky D
    Dev Biol Stand; 1999; 97():157-68. PubMed ID: 10463541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.